Prostate Cancer News on BioPortfolio

Georgia Men at High Risk for Prostate Cancer

Race and Distrust Contribute to High Death Rate WASHINGTON March 8 2012 PRNewswireUSNewswire &160;Factors such as increased risk for AfricanAmericans and medical distrust contribute to high rates of prostate cancer in Georgia. Georgia has the fifth h...

Mississippi Men at High Risk for Prostate Cancer

&160;&160;&160;&160;&160;&160;&160;&160;&160;&160; Obesity and Distrust Contribute to High Death Rate WASHINGTON March 8 2012 PRNewswireUSNewswire &160;Factors such increased risk for AfricanAmericans obesity a...

Louisiana Men at High Risk for Prostate Cancer

&160; Obesity and Distrust Contribute to High Death Rate WASHINGTON March 8 2012 PRNewswireUSNewswire &160;Factors such as increased risk for AfricanAmericans obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. ...

DC Leads Nation in Prostate Cancer

Race and Distrust Leading Factors in Death Rate WASHINGTON March 8 2012 PRNewswireUSNewswire &160;Increased risk for AfricanAmericans medical distrust and negative attitudes toward testing contribute to high rates of prostate cancer in the District o...

Bellicum Closes $20 Million Series B Financing

HOUSTON March 8 2012 PRNewswire &160;Bellicum Pharmaceuticals Inc. today announced that it has raised $20 million in a Series B financing. The funding will be used to advance its lead CaspaCIDe&8482; and DeCIDe&8482; programs through Phase 2 cl...

Michael Milken Joins Focused Ultrasound Foundation Council

CHARLOTTESVILLE Va. March 7 2012 PRNewswireUSNewswire The Focused Ultrasound Foundation announced today that medical research activist philanthropist and financier Michael Milken has joined its Council a select group of advisors and advocates who are help...

Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export SINE in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research AACR Meeting

NATICK Mass. March 7 2012 PRNewswire Karyopharm Therapeutics Inc. a leader in the new field of nuclear transport modulators announces nine presentations covering its Selective Inhibitors of Nuclear Export SINE oral small molecule CRM1 antagonists at th...

Endocyte bounces back with latestage prostate cancer deal

Endocyte saw its share price take off yesterday after it acquired rights to a promising latestage cancer therapy.The companys stock rose more than 150 in a day with investors sensing that the new deal with German biotech ABX could result in...

Pages